Daniel Ho

3.5k total citations · 1 hit paper
18 papers, 2.3k citations indexed

About

Daniel Ho is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel Ho has authored 18 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel Ho's work include Mitochondrial Function and Pathology (5 papers), Genetic Neurodegenerative Diseases (4 papers) and Biochemical Acid Research Studies (3 papers). Daniel Ho is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Genetic Neurodegenerative Diseases (4 papers) and Biochemical Acid Research Studies (3 papers). Daniel Ho collaborates with scholars based in United States, Switzerland and China. Daniel Ho's co-authors include Noel Y. Calingasan, Ajamete Kaykas, Robert J. Ihry, M. Flint Beal, Magali Dumont, Kathleen A. Worringer, Sravya Kommineni, Elizabeth Wille, Max R. Salick and Gregory McAllister and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Daniel Ho

18 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

2018 658 citations Robert J. Ihry, Kathleen A. Worringer et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ho United States	17	1.5k	352	313	278	212	18	2.3k
Jason DeVoss United States	35	829 0.6×	403 1.1×	516 1.6×	304 1.1×	303 1.4×	49	3.4k
Hidetoshi Kumagai Japan	26	1.6k 1.1×	335 1.0×	164 0.5×	354 1.3×	218 1.0×	56	3.0k
Letizia Venturini Germany	24	1.6k 1.0×	228 0.6×	215 0.7×	320 1.2×	200 0.9×	63	2.5k
Sharon Frase United States	24	1.8k 1.2×	513 1.5×	129 0.4×	219 0.8×	310 1.5×	43	2.6k
Giovanni Perini Italy	33	2.4k 1.6×	425 1.2×	427 1.4×	218 0.8×	167 0.8×	69	3.3k
Xiaohui Wu China	27	2.5k 1.7×	334 0.9×	593 1.9×	248 0.9×	220 1.0×	85	3.5k
Fred E. Indig United States	31	2.5k 1.7×	535 1.5×	217 0.7×	403 1.4×	143 0.7×	55	3.5k
Qianwa Liang United States	22	973 0.6×	203 0.6×	554 1.8×	483 1.7×	134 0.6×	38	2.5k
Cheryl B. Bock United States	24	1.5k 1.0×	252 0.7×	231 0.7×	304 1.1×	115 0.5×	35	2.9k
John Ryder United States	28	1.1k 0.7×	424 1.2×	173 0.6×	729 2.6×	213 1.0×	64	2.8k

Countries citing papers authored by Daniel Ho

Since Specialization

Citations

This map shows the geographic impact of Daniel Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ho more than expected).

Fields of papers citing papers by Daniel Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ho. The network helps show where Daniel Ho may publish in the future.

Co-authorship network of co-authors of Daniel Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ho. A scholar is included among the top collaborators of Daniel Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ho. Daniel Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Jadhav, Bharati, Ramin Monajemi, Kristina Gagalova, et al.. (2019). RNA-Seq in 296 phased trios provides a high-resolution map of genomic imprinting. BMC Biology. 17(1). 50–50. 22 indexed citations

Ihry, Robert J., Kathleen A. Worringer, Max R. Salick, et al.. (2018). p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells. Nature Medicine. 24(7). 939–946. 658 indexed citations breakdown →

Ye, Chaoyang, Daniel Ho, Marilisa Neri, et al.. (2018). DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nature Communications. 9(1). 4307–4307. 135 indexed citations

Feuerbach, Dominik, Patrick Schindler, Carmen Barske, et al.. (2017). ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neuroscience Letters. 660. 109–114. 109 indexed citations

Watson, Corey T., Panos Roussos, Paras Garg, et al.. (2016). Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease. Genome Medicine. 8(1). 5–5. 146 indexed citations

Wells, Michael F., Max R. Salick, Ole Wiskow, et al.. (2016). Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection. Cell stem cell. 19(6). 703–708. 211 indexed citations

Li, Yang, Daniel Ho, Huan Meng, et al.. (2012). Direct Detection of Collagenous Proteins by Fluorescently Labeled Collagen Mimetic Peptides. Bioconjugate Chemistry. 24(1). 9–16. 87 indexed citations

Yao, Jiaqi, Daniel Ho, Noel Y. Calingasan, et al.. (2012). Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. The Journal of Experimental Medicine. 209(13). 2501–2513. 122 indexed citations

Thomas, Bobby, Rebecca Banerjee, Natalia N. Starkova, et al.. (2011). Mitochondrial Permeability Transition Pore Component Cyclophilin D Distinguishes Nigrostriatal Dopaminergic Death Paradigms in the MPTP Mouse Model of Parkinson's Disease. Antioxidants and Redox Signaling. 16(9). 855–868. 47 indexed citations

10.

Stack, Cliona, Daniel Ho, Elizabeth Wille, et al.. (2010). Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radical Biology and Medicine. 49(2). 147–158. 143 indexed citations

11.

Ho, Daniel, Noel Y. Calingasan, Elizabeth Wille, Magali Dumont, & M. Flint Beal. (2010). Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Experimental Neurology. 225(1). 74–84. 114 indexed citations

12.

Nguyen, Linda M.‐D., Peter J. Adhihetty, Thomas Hennessey, et al.. (2010). Effect of Metformin Treatment on Skeletal Muscle Cell Death Pathways in Huntington's Disease. Medicine & Science in Sports & Exercise. 42(10). 10–10. 2 indexed citations

13.

Dumont, Magali, Daniel Ho, Noel Y. Calingasan, et al.. (2009). Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radical Biology and Medicine. 47(7). 1019–1027. 63 indexed citations

14.

Yang, Lichuan, Qingli Shi, Daniel Ho, et al.. (2009). Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins. Neurobiology of Disease. 36(2). 320–330. 22 indexed citations

15.

Calingasan, Noel Y., Daniel Ho, Elizabeth Wille, et al.. (2008). Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neuroscience. 153(4). 986–996. 60 indexed citations

16.

Schönleben, Frank, John Allendorf, Wanglong Qiu, et al.. (2008). Mutational Analyses of Multiple Oncogenic Pathways in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 36(2). 168–172. 32 indexed citations

17.

Qiu, Wanglong, Frank Schönleben, Xiaojun Li, et al.. (2006). PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 12(5). 1441–1446. 166 indexed citations

18.

Schönleben, Frank, Wanglong Qiu, Daniel Ho, et al.. (2006). PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas. Clinical Cancer Research. 12(12). 3851–3855. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact